Ouabain Octahydrate
Cat. No.：YN360796
| 产品名称: | Ouabain Octahydrate |
| CAS No.: | 11018-89-6 |
| Chemical Name: | (1β,3β,5β,11α)-3-[(6-Deoxy-α-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide Octahydrate; g-Strophanthin Octahydrate; |
| Synonyms: | Acocantherine; G-Strophanthin |
| 分子量: | 728.77 |
| 分子式: | C₂₉H₆₀O₂₀ |
| SMILES: | OC[C@@]([C@](CC1)(C[C@@H](O[C@@](O[C@@H](C)[C@H](O)[C@H]2O)([H])[C@@H]2O)C3)O)([C@@H]3O)[C@]([C@@H](C[C@@]45C)O)([H])[C@]1([H])[C@]4(CC[C@@H]5C(CO6)=CC6=O)O.[8 H2O] |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Ouabain Octahydrate 是Na+/K+-ATPase抑制剂，有潜力用于充血性心力衰竭的研究。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Padilha, A.S. et al.: Clin. Exp. Pharmacol. Physiol., 35, 801 (2008)
Blaustein, M.P. et al.: Clin. Exp. Hypertens. 20, 691 (1998)
van Huysse, J.W. et al.: Clin. Exp. Hypertens. 20, 657 (1998)
